Notably, blocking IL-8–like signaling through CXCR-1/-2 decreased disease severity in our murine model of SARS-CoV-2–associated acute respiratory distress syndrome (ARDS). The gene discussed is CXCR1; the disease is acute respiratory distress syndrome.